The ‘Meniere’s Disease Epidemiology Forecast to 2030‘ report from DelveInsight provides an in-depth overview of the disease, as well as historical and forecasted Meniere’s Disease epidemiology in the 7MM (the United States, the EU5, Italy, France, and the United Kingdom), and Japan.
The Meniere’s Disease epidemiology report provides a comprehensive explanation of the disease symptoms and causes, as well as risk factors, diagnosis, pathophysiology, and treatment guidelines for Meniere’s Disease in 7MM.
The epidemiology of Meniere’s Disease is broken down into total diagnosed incident cases, age, gender, type-specific diagnosed incident cases, diagnosed incident population based on Meniere’s Disease’s primary site, and diagnosed incident population based on Meniere’s Disease’s histologic classification.
Request for Sample @ Meniere’s Disease Epidemiology Report
Key Highlights of the Meniere’s Disease Epidemiology Report:
- According to the Hearing Health Foundation, it’s estimated that there are 600,000-750,000 cases of Ménière’s disease in the United States, with 45,000 to 60,000 new cases diagnosed annually. Worldwide, Ménière’s disease impacts 12 in 1000 people.
- According to the research study of Minor et al., the prevalence of Meniere’s Disease in the United Kingdom is estimated to be around 1 in 1000 people, with women being somewhat more affected than males.
- According to DelveInsight’s analysis, the frequency of male/female prevalence in Meniere’s disease has been noted to be generally equal with perhaps some slight female preponderance up to 1.3:1.
Visit to get a more detailed insight into the patient pool @ Meniere’s Disease Epidemiology and Patient Population
Meniere’s Disease Disease Overview
Ménière’s Disease (MD) is a condition marked by recurrent vertigo (vertigo), potential hearing loss, and ringing in the ears (tinnitus). It’s linked to a dilatation of the ear’s membranous labyrinth (endolymphatic hydrops).
Dizziness (vertigo) attacks in MD strike unexpectedly and linger for a few hours. The impression that the room or things are revolving around the patient is known as vertigo. The dizziness usually fades over time. Nausea and vomiting are possible side effects of the attacks.
Meniere’s Disease is most typically diagnosed in people in their fifth decade of life. However, symptoms may appear in young adults or the elderly in some circumstances. Males and females appear to be equally affected by the disease. However, a few studies have found that it was more common in people who were older, had higher BMI categories, and were white and female.
The diagnosis of Meniere’s disease is by exclusion, and a careful history is the most important guide to a correct diagnosis.
Dive deeper to know more @ Meniere’s Disease Disease Background and Overview
Meniere’s Disease Epidemiology Segmentation:
- Prevalent Cases of Meniere’s Disease
- Diagnosed Prevalent cases of Meniere’s Disease
- Age-specific Diagnosed Prevalent cases of Meniere’s Disease
- Gender-specific Diagnosed Prevalent cases of Meniere’s Disease
- Severity-specific Diagnosed Prevalent cases of Meniere’s Disease
Check out for more @ Meniere’s Disease Prevalent and Diagnosed Cases
Scope of the Report:
- Detailed segmentation of the Meniere’s Disease epidemiology.
- A historical and forecasted patient pool of Meniere’s Disease in 7MM.
- Assessment of the growth opportunities in the 7MM with respect to the Meniere’s Disease patient population.
- Detailed analysis of Meniere’s Disease symptoms, causes, diagnosis, classification, pathophysiology, and its treatment patterns.
- A comprehensive evaluation of the disease in terms of its burden, and the unmet needs.
- Overview of the risk factors and trends of Meniere’s Disease in 7MM.
Got queries? Reach out for more information @ Meniere’s Disease Market Research Report
Table of Contents:
| 1. | Key Insights |
| 2. | Report Introduction |
| 3. | Meniere’s Disease: Overview at a Glance |
| 4. | Disease Background and Overview: Meniere’s Disease |
| 5. | Meniere’s Disease: Epidemiology and Patient Population |
| 6. | KOL Views |
| 7. | Appendix |
| 8. | DelveInsight’s Capabilities |
| 9. | Disclaimer |
| 10. | About DelveInsight |
Key Highlight of the Reports:
- Geographies Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
- Study Period: 2017–2030
- Key Assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
Related Reports:
DelveInsight’s “Meniere’s Disease Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Meniere’s Disease (MD) , historical and forecasted epidemiology as well as the Meniere’s Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Meniere’s Disease (MD) Pipeline
DelveInsight’s “Meniere’s Disease (MD) – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Meniere’s Disease (MD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight’s “Tinnitus – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Tinnitus, historical and forecasted epidemiology as well as the Tinnitus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight’s “Tinnitus – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 9+ pipeline drugs in the Tinnitus pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight’s ‘Tinnitus – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Tinnitus epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Healthcare Blogs:
Age-related Hearing Loss Device Market Dynamics Expected to Step into Growth Quadrant
Who is Going to be a Trendsetter in the Hereditary Deafness Market?
Healthcare in 2021: Top Disruptions Bound To Impact The Way Healthcare Is Delivered
Get in touch with our Business executive for Competitive Intelligence Services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Contact Information:
Kritika Rehani info@delveinsight.com +1(919)321-6187
Tags:
Reportedtimes, PR-Wirein, Menafn, IPS, Extended Distribution, iCN Internal Distribution, Research Newswire, English
Contact Information:
Kritika Rehani
info@delveinsight.com
+1(919)321-6187
